In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent ...

A new strategy for tuberculosis (TB) screening provides a solution to problems with current TB screening, which does not always accurately detect disease. Simultaneously screening for both active and ...

In a lab in the heart of Boston, professor Bree Aldridge leads a team of researchers trying to understand a threat that is ...

Fund has awarded a $4.5m grant to US-based diagnostic developer Fluxus, a Fujirebio subsidiary, to develop an ultrasensitive ...

A new strategy for tuberculosis (TB) screening, proposed by a team of researchers led by Queen Mary University of London, provides a solution to problems with current TB screening, which does not ...

Priya (name changed), a 35-year-old woman, was rushed to the intensive care unit of a local hospital. For months, she had dismissed the persistent cough and occasional chest pains, telling her ...

"This approval means that newly diagnosed patients can receive daratumumab subcutaneous plus VRd and avoid the need for lengthy IV infusions." This approval follows the indication extension ...

HIV, cancer, and tuberculosis (TB) patients in Kenya have called upon the Members of Parliament to review the Kenya-United Arab Emirates Comprehensive Economic Partnership Agreement (CEPA) signed on ...

For example, patients may struggle to produce enough sputum for a TB test. The paucibacillary nature of the disease, meaning TB infections often have a low bacterial load, also results in false ...

NEW YORK – Johnson & Johnson on Monday said the European Commission approved subcutaneous Rybrevant (amivantamab) as a treatment for patients with advanced non-small cell lung cancers bearing certain ...

Kalaburagi: Dr Farooq Ahmad Manoor of Manur Hospital, Kalaburagi, has taken responsibility for 250 tuberculosis patients by providing them nutrition support, contributing to the TB-Mukt India ...